Buchmann M S, Björkhem I, Skrede S
Institute of Clinical Biochemistry, Rikshospitalet, University of Oslo, Norway.
Biochim Biophys Acta. 1987 Nov 21;922(2):111-7. doi: 10.1016/0005-2760(87)90144-5.
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease where the basic defect is a lack of the mitochondrial C27-steroid 26-hydroxylase involved in bile acid synthesis (EC 1.14.13.15). Cholestanol and cholesterol accumulate in all tissues. At least part of the accumulation of cholestanol is due to a 7 alpha-dehydroxylation of early bile acid intermediates. Cholesta-4,6-dien-3-one, a proposed intermediate in this pathway, is found in increased concentrations in serum of the patients. This study shows that cholesta-4,6-dien-3-one may be metabolized to 4-cholesten-3-one and cholestanol by liver, adrenals and brain. No conversion was found in intestinal mucosa or in kidneys. The capacity to convert cholesta-4,6-dien-3-one into 4-cholesten-3-one and cholestanol varied in different tissues as well as in different species. The results are discussed in relation to the cholestanol accumulation in CTX.
脑腱黄瘤病(CTX)是一种脂质贮积病,其基本缺陷是缺乏参与胆汁酸合成的线粒体C27 - 类固醇26 - 羟化酶(EC 1.14.13.15)。胆甾烷醇和胆固醇在所有组织中蓄积。胆甾烷醇的蓄积至少部分归因于早期胆汁酸中间体的7α - 脱羟基作用。胆甾 - 4,6 - 二烯 - 3 - 酮是该途径中的一种假定中间体,在患者血清中的浓度升高。本研究表明,胆甾 - 4,6 - 二烯 - 3 - 酮可被肝脏、肾上腺和脑代谢为4 - 胆甾烯 - 3 - 酮和胆甾烷醇。在肠黏膜或肾脏中未发现转化。将胆甾 - 4,6 - 二烯 - 3 - 酮转化为4 - 胆甾烯 - 3 - 酮和胆甾烷醇的能力在不同组织以及不同物种中有所不同。结合CTX中胆甾烷醇的蓄积对结果进行了讨论。